BACKGROUND: Natural killer (NK) cells are implicated in the pathogenesis of hepatitis C virus (HCV) infection and outcome of interferon (IFN)-α based therapy, although mechanisms remain unclear. METHODS: To evaluate NK ability to control HCV infection, we analyzed healthy donor and HCV-infected donor NK-cell cytolytic activity directed at HCV-infected target cells. RESULTS: HCV-infected subjects' natural cytotoxicity receptor (NCR)-dependent NK-cell cytolytic activity directed at HCV-infected and uninfected Huh7.5 target cells was greater than that of cells from healthy donors, and this localized to the African American subset. However, IFN-α-enhanced NK cytolytic function was lower in HCV-infected subjects, again localized mainly to the African American subset. Additionally, whereas HCV-infected Huh7.5 cells were more readily targeted than uninfected cells, the selectivity of cytolytic activity for infected targets was lower during HCV infection and after IFN-α stimulation, and lower selectivity was in part attributable to greater NKp46 expression. Furthermore, cytolytic activity was associated with higher serum aspartate aminotransferase, rs12979860 IL28B genotype, and in vivo response to pegylated IFN/ribavirin therapy. CONCLUSIONS: These data indicate that during chronic HCV infection, race-associated increase in NCR expression and IL28B-associated cytolytic activity may participate in host response to IFN-α-containing HCV therapy.
BACKGROUND: Natural killer (NK) cells are implicated in the pathogenesis of hepatitis C virus (HCV) infection and outcome of interferon (IFN)-α based therapy, although mechanisms remain unclear. METHODS: To evaluate NK ability to control HCV infection, we analyzed healthy donor and HCV-infected donor NK-cell cytolytic activity directed at HCV-infected target cells. RESULTS:HCV-infected subjects' natural cytotoxicity receptor (NCR)-dependent NK-cell cytolytic activity directed at HCV-infected and uninfected Huh7.5 target cells was greater than that of cells from healthy donors, and this localized to the African American subset. However, IFN-α-enhanced NK cytolytic function was lower in HCV-infected subjects, again localized mainly to the African American subset. Additionally, whereas HCV-infected Huh7.5 cells were more readily targeted than uninfected cells, the selectivity of cytolytic activity for infected targets was lower during HCV infection and after IFN-α stimulation, and lower selectivity was in part attributable to greater NKp46 expression. Furthermore, cytolytic activity was associated with higher serum aspartate aminotransferase, rs12979860IL28B genotype, and in vivo response to pegylated IFN/ribavirin therapy. CONCLUSIONS: These data indicate that during chronic HCV infection, race-associated increase in NCR expression and IL28B-associated cytolytic activity may participate in host response to IFN-α-containing HCV therapy.
Authors: Henry Ogbomo; Anke Hahn; Janina Geiler; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl Journal: Biochem Biophys Res Commun Date: 2005-11-14 Impact factor: 3.575
Authors: Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian Willberg; Kwok Tang; Phillipa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow Journal: J Virol Date: 2005-10 Impact factor: 5.103
Authors: Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony Journal: J Virol Date: 2009-03-18 Impact factor: 5.103
Authors: Barbara Oliviero; Stefania Varchetta; Enrica Paudice; Giuseppe Michelone; Marco Zaramella; Domenico Mavilio; Francesca De Filippi; Savino Bruno; Mario U Mondelli Journal: Gastroenterology Date: 2009-05-24 Impact factor: 22.682
Authors: L Golden-Mason; L Madrigal-Estebas; E McGrath; M J Conroy; E J Ryan; J E Hegarty; C O'Farrelly; D G Doherty Journal: Gut Date: 2008-03-27 Impact factor: 23.059
Authors: N Paladino; A C Flores; C Y Marcos; H Fainboim; G Theiler; L Arruvito; F Williams; D Middleton; L Fainboim Journal: Tissue Antigens Date: 2007-04
Authors: Chelsey J Judge; Lenche Kostadinova; Kenneth E Sherman; Adeel A Butt; Yngve Falck-Ytter; Nicholas T Funderburg; Alan L Landay; Michael M Lederman; Scott F Sieg; Johan K Sandberg; Donald D Anthony Journal: J Leukoc Biol Date: 2017-04-11 Impact factor: 4.962
Authors: Rikke Olesen; Selena Vigano; Thomas A Rasmussen; Ole S Søgaard; Zhengyu Ouyang; Maria Buzon; Arman Bashirova; Mary Carrington; Sarah Palmer; Christel R Brinkmann; Xu G Yu; Lars Østergaard; Martin Tolstrup; Mathias Lichterfeld Journal: J Virol Date: 2015-07-29 Impact factor: 5.103
Authors: Chelsey J Judge; Elane Reyes-Aviles; Sara J Conry; Scott S Sieg; Zhimin Feng; Aaron Weinberg; Donald D Anthony Journal: Cell Immunol Date: 2015-06-30 Impact factor: 4.868
Authors: Hiroto Kambara; Lalith Gunawardane; Elizabeth Zebrowski; Lenche Kostadinova; Raul Jobava; Dawid Krokowski; Maria Hatzoglou; Donald D Anthony; Saba Valadkhan Journal: Front Immunol Date: 2015-01-30 Impact factor: 7.561
Authors: Ahmed Lasfar; Andrew de laTorre; Walid Abushahba; Karine A Cohen-Solal; Ismael Castaneda; Yao Yuan; Kenneth Reuhl; Andrew Zloza; Elizabeth Raveche; Debra L Laskin; Sergei V Kotenko Journal: Oncotarget Date: 2016-08-02